ID

13874

Beschreibung

Feasibility and Toxicity of Degarelix for Prostate Downsizing Prior to Permanent Seed Prostate Brachytherapy; ODM derived from: https://clinicaltrials.gov/show/NCT01446991

Link

https://clinicaltrials.gov/show/NCT01446991

Stichworte

  1. 13.03.16 13.03.16 -
Hochgeladen am

13. März 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :


Keine Kommentare

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Prostate Cancer NCT01446991

Eligibility Prostate Cancer NCT01446991

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologic diagnosis of prostate cancer
Beschreibung

prostate cancer

Datentyp

boolean

Alias
UMLS CUI [1]
C0600139
favorable risk disease (ct1 or t2a, gleason score (gs) 6, and prostate specific antigen (psa) < 10 ng/ml)
Beschreibung

tumor stage; gleason score; prostate specific antigen

Datentyp

boolean

Alias
UMLS CUI [1]
C1300072
UMLS CUI [2]
C3203027
UMLS CUI [3]
C0138741
low-tier intermediate risk disease (ct2c,gs=6,and psa 10-15 ng/ml, or gs=7 and psa < 10 ng/ml)
Beschreibung

tumor stage; gleason score; prostate specific antigen

Datentyp

boolean

Alias
UMLS CUI [1]
C1300072
UMLS CUI [2]
C3203027
UMLS CUI [3]
C0138741
intermediate risk disease and androgen deprivation therapy recommended by the treating physician for oncologic reasons such as (≥ 50% positive biopsy cores,ct2c,psa 15-20 ng/ml,gs=7)
Beschreibung

Antiandrogen therapy; positive biopsy cores; tumor stage; gleason score; prostate specific antigen

Datentyp

boolean

Alias
UMLS CUI [1]
C0279492
UMLS CUI [2]
C1276779
UMLS CUI [3]
C1300072
UMLS CUI [4]
C3203027
UMLS CUI [5]
C0138741
patient requires baseline planning trans-rectal ultrasound for the purposes of prostate brachytherapy, showing prostate volume > 40 ml and pubic arch interference (not required for those requiring androgen ablation for oncologic reasons)
Beschreibung

trans-rectal ultrasound prostate volume for prostate brachytherapy; androgen ablation

Datentyp

boolean

Alias
UMLS CUI [1]
C0812546
UMLS CUI [2]
C1515985
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
castrate serum testosterone level
Beschreibung

serum testosterone

Datentyp

boolean

Alias
UMLS CUI [1]
C0428413
previous or concurrent pelvic radiotherapy
Beschreibung

pelvic radiotherapy

Datentyp

boolean

Alias
UMLS CUI [1]
C0436276
unable to give written informed consent
Beschreibung

informed consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
contraindications to permanent seed prostate brachytherapy or to androgen deprivation therapy
Beschreibung

prostate brachytherapy; Antiandrogen therapy

Datentyp

boolean

Alias
UMLS CUI [1]
C0854662
UMLS CUI [2]
C0279492
prior treatment for prostate cancer
Beschreibung

Study Subject Participation Status

Datentyp

boolean

Alias
UMLS CUI [1]
C2348568
prior trans-urethral resection of the prostate
Beschreibung

Transurethral Resection of Prostate

Datentyp

boolean

Alias
UMLS CUI [1]
C0040771
previous therapy with a 5-α reductase inhibitor, anti-androgen agent, or lhrh agonist
Beschreibung

therapy 5-alpha Reductase Inhibitors Androgen Antagonists; Luteinizing Hormone-releasing Hormone Agonist

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C2936788
UMLS CUI [1,3]
C0002842
UMLS CUI [1,4]
C1518041
previous therapy with degarelix
Beschreibung

therapy degarelix

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C1455035

Ähnliche Modelle

Eligibility Prostate Cancer NCT01446991

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
prostate cancer
Item
histologic diagnosis of prostate cancer
boolean
C0600139 (UMLS CUI [1])
tumor stage; gleason score; prostate specific antigen
Item
favorable risk disease (ct1 or t2a, gleason score (gs) 6, and prostate specific antigen (psa) < 10 ng/ml)
boolean
C1300072 (UMLS CUI [1])
C3203027 (UMLS CUI [2])
C0138741 (UMLS CUI [3])
tumor stage; gleason score; prostate specific antigen
Item
low-tier intermediate risk disease (ct2c,gs=6,and psa 10-15 ng/ml, or gs=7 and psa < 10 ng/ml)
boolean
C1300072 (UMLS CUI [1])
C3203027 (UMLS CUI [2])
C0138741 (UMLS CUI [3])
Antiandrogen therapy; positive biopsy cores; tumor stage; gleason score; prostate specific antigen
Item
intermediate risk disease and androgen deprivation therapy recommended by the treating physician for oncologic reasons such as (≥ 50% positive biopsy cores,ct2c,psa 15-20 ng/ml,gs=7)
boolean
C0279492 (UMLS CUI [1])
C1276779 (UMLS CUI [2])
C1300072 (UMLS CUI [3])
C3203027 (UMLS CUI [4])
C0138741 (UMLS CUI [5])
trans-rectal ultrasound prostate volume for prostate brachytherapy; androgen ablation
Item
patient requires baseline planning trans-rectal ultrasound for the purposes of prostate brachytherapy, showing prostate volume > 40 ml and pubic arch interference (not required for those requiring androgen ablation for oncologic reasons)
boolean
C0812546 (UMLS CUI [1])
C1515985 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
serum testosterone
Item
castrate serum testosterone level
boolean
C0428413 (UMLS CUI [1])
pelvic radiotherapy
Item
previous or concurrent pelvic radiotherapy
boolean
C0436276 (UMLS CUI [1])
informed consent
Item
unable to give written informed consent
boolean
C0021430 (UMLS CUI [1])
prostate brachytherapy; Antiandrogen therapy
Item
contraindications to permanent seed prostate brachytherapy or to androgen deprivation therapy
boolean
C0854662 (UMLS CUI [1])
C0279492 (UMLS CUI [2])
Study Subject Participation Status
Item
prior treatment for prostate cancer
boolean
C2348568 (UMLS CUI [1])
Transurethral Resection of Prostate
Item
prior trans-urethral resection of the prostate
boolean
C0040771 (UMLS CUI [1])
therapy 5-alpha Reductase Inhibitors Androgen Antagonists; Luteinizing Hormone-releasing Hormone Agonist
Item
previous therapy with a 5-α reductase inhibitor, anti-androgen agent, or lhrh agonist
boolean
C0087111 (UMLS CUI [1,1])
C2936788 (UMLS CUI [1,2])
C0002842 (UMLS CUI [1,3])
C1518041 (UMLS CUI [1,4])
therapy degarelix
Item
previous therapy with degarelix
boolean
C0087111 (UMLS CUI [1,1])
C1455035 (UMLS CUI [1,2])

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video